Publications by authors named "Annick Ruffault"

Claim this Profile
A
Algorithm-based prediction of HIV-1 subtype D coreceptor use.
Julia Dina, Stephanie Raymond, Anne Maillard, Helene Le Guillou-Guillemette, Audrey Rodalec, Annick Ruffault

J Clin Microbiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
Lambert Assoumou, Diane Descamps, Sabine Yerly, Georges Dos Santos, Anne-Geneviève Marcelin, Annick Ruffault

J Antimicrob Chemother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Anne-Genevieve Marcelin, Diane Descamps, Catherine Tamalet, Jacqueline Cottalorda, Jacques Izopet, Annick Ruffault

Antivir Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus infects human seminal vesicles in vitro and in vivo.
Claire Deleage, Marina Moreau, Nathalie Rioux-Leclercq, Annick Ruffault, Bernard Jégou

Am J Pathol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.
Patricia Recordon-Pinson, Cathia Soulié, Philippe Flandre, Diane Descamps, Mouna Lazrek, Annick Ruffault

Antimicrob Agents Chemother· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
Anne-Genevieve Marcelin, Philippe Flandre, Diane Descamps, Laurence Morand-Joubert, Charlotte Charpentier, Annick Ruffault

Antimicrob Agents Chemother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology, efficacy and safety of atazanavir: a review.
Danièle Bentué-Ferrer, Cédric Arvieux, Olivier Tribut, Annick Ruffault, Eric Bellissant

Expert Opin Drug Metab Toxicol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.
Marianne Burgard, Faroudy Boufassa, Jean-Paul Viard, Isabelle Garrigue, Annick Ruffault

AIDS· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo.
Anna Le Tortorec, Anne-Pascale Satie, Hélène Denis, Nathalie Rioux-Leclercq, Laurence Havard, Annick Ruffault

Retrovirology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
Diane Descamps, Lambert Assoumou, Bernard Masquelier, Anne-Geneviève Marcelin, Souhila Saidi, Annick Ruffault

J Antimicrob Chemother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Anne-Genevieve Marcelin, Bernard Masquelier, Diane Descamps, Jacques Izopet, Charlotte Charpentier, Annick Ruffault

Antimicrob Agents Chemother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.
Dominique Costagliola, Diane Descamps, Lambert Assoumou, Laurence Morand-Joubert, Anne-Geneviève Marcelin, Annick Ruffault

J Acquir Immune Defic Syndr· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.
Marie Gueudin, Jean Christophe Plantier, Véronique Lemée, Marie Paule Schmitt, Loic Chartier, Annick Ruffault

J Acquir Immune Defic Syndr· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple organ failure during primary HIV infection.
Pierre Tattevin, Christophe Camus, Cédric Arvieux, Annick Ruffault, Christian Michelet

Clin Infect Dis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Anne Maillard, Jean-Marc Chapplain, Olivier Tribut, Danièle Bentué-Ferrer, Pierre Tattevin, Annick Ruffault

J Clin Virol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro.
Vanessa Roulet, Anne-Pascale Satie, Annick Ruffault, Anna Le Tortorec, Hélène Denis

Am J Pathol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
Diane Descamps, Constance Delaugerre, Bernard Masquelier, Annick Ruffault, Anne-Geneviève Marcelin

J Med Virol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Anne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, Philippe Colson, Emmanuel Guillevic, Annick Ruffault

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.
Diane Descamps, Marie-Laure Chaix, Patrice André, Véronique Brodard, Jacqueline Cottalorda, Annick Ruffault

J Acquir Immune Defic Syndr· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 group M superinfection in an HIV-1 group O-infected patient.
Jean-Christophe Plantier, Véronique Lemée, Iann Dorval, Marie Gueudin, Joséphine Braun, Annick Ruffault

AIDS· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients.
Bernard Masquelier, Catherine Tamalet, Brigitte Montès, Diane Descamps, Gilles Peytavin, Annick Ruffault

Antivir Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.
Marie-Laure Chaix, Diane Descamps, Martine Harzic, Véronique Schneider, Christiane Deveau, Annick Ruffault

AIDS· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically relevant interpretation of genotype for resistance to abacavir.
Françoise Brun-Vézinet, Diane Descamps, Annick Ruffault, Bernard Masquelier, Vincent Calvez

AIDS· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of the antiviral proteins 2'5'oligoadenylate synthetase, PKR and Mx in interstitial cells and spermatogonia.
Nathalie Melaine, Marie-Odile Liénard, Elisabeth Guillaume, Annick Ruffault, Nathalie Dejucq-Rainsford

J Reprod Immunol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mumps virus decreases testosterone production and gamma interferon-induced protein 10 secretion by human leydig cells.
Ronan Le Goffic, Thomas Mouchel, Annick Ruffault, Jean-Jacques Patard, Bernard Jégou

J Virol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis